Our commitment starts here.
Find. Fight. Follow.™
Our commitment starts here.
Find. Fight. Follow.™
Our commitment starts here.
Find. Fight. Follow.™
Data provided by Nasdaq.
Minimum 15 minutes delayed.
For more than half a century, our diagnostic and therapeutic innovations have changed the way clinicians Find, Fight and Follow® disease. Today, we go further still—with the same sense of purpose and commitment to empowering healthcare professionals with life-changing science that helps improve outcomes and lives.
Worldwide revenue of $223.7 million for the second quarter 2022, representing an increase of 121.4% from the prior year period GAAP net income of $43.1 million for the second quarter 2022, compared to GAAP net loss of $26.7 million in the prior year period GAAP fully diluted net income per share of
Read MoreNORTH BILLERICA, Mass. , July 21, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, August 4, 2022 , to discuss its financial and operating results for the second quarter of
Read MoreDottie Barr Promoted to Senior Vice President, Manufacturing and Technical Operations NORTH BILLERICA, Mass. , June 15, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH), today announced two key management promotions. Paul Blanchfield has been promoted to Chief
Read MoreStudy Results Presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting NORTH BILLERICA, Mass. , June 13, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH) is committed to improving patient outcomes through diagnostics, radiotherapeutics
Read More